Reading Time: 2 minutesIt was then back to the science. Prof Frank Soldner (Massachusetts Institute of Technology) provided an overview of a new and exciting way in which
Month: January 2011
Reading Time: 2 minutesThe room was crowded at 8am for the first presentation of day two, from Dr Doug Sipp (RIKEN Institute, Japan) on ‘Unregulated ALS/MND treatments and public education’. Dr
Reading Time: 2 minutesOne human neural stem cell line that has cleared the US Government’s regulatory hurdles is that developed by the biotechnology company Neuralstem. To date, nine
Reading Time: 2 minutesThe remainder of the morning covered some of the preclinical research that has laid the foundations for current and forthcoming clinicalstudies. Prof Clive Svendsen, from University Wisconsin-Madison, gave an
Reading Time: < 1 minuteThe possibility of using stem cells for drug screening was covered in more detail by Prof Chris Henderson from Columbia University New York. Prof Henderson has
Reading Time: 2 minutesCreating motor neurones for research is a lengthy and expensive process, so Prof Kevin Eggan from Harvard University Massachusetts, asked whether we can predict at an
Reading Time: 2 minutesIt was a chilly -15oC in New York on Sunday night, but the temperature on Monday morning was considerably higher – fuelled in part by
Reading Time: < 1 minuteSixty of the world’s leading stem cell research experts are meeting in New York, USA on 24 to 25 January to discuss and debate MND
Reading Time: 3 minutesTissue donation has played a vital role in many important MND research findings. Without the generosity of individuals who decide to donate their brains and spinal cords to